Cyclic immunofluorescence (cyclic IF) is transforming spatial biology by enabling highly multiplexed protein detection while preserving tissue architecture.

Join Dr Oliver Hartmann, Senior Scientific Officer and Post-Doc, to discover how primary antibody labeling can advance cyclic IF workflows for the identification and characterization of novel lung cancer therapeutics.

Dr Hartmann will explore key considerations for selecting and labeling antibodies, strategies to improve multiplex imaging performance, and how these approaches can be applied to accelerate biomarker discovery and therapeutic development in lung cancer research.

This webinar will cover:

• The principles of cyclic IF and its role in drug discovery

• Novel antibody labeling techniques to support robust multiplex imaging

• Considerations for minimizing cross-reactivity and maximizing signal quality across multiple staining cycles

• Applications of cyclic IF for identifying and validating novel therapeutic targets in lung cancer

Attendees will receive:

• In-depth Q&A with Dr Hartmann

• Free product sample code

• Certificate of attendance*

• Recording of the session

*The name provided for registration is the name that will appear on the certificate of attendance